CORAL LABORATORIES
|
The Current P/E Ratio of CORAL LABORATORIES is 9.37.
| Share Price | ₹500.2 | Nov 08,2026 |
| Market Cap | ₹180.1 Cr | |
| Earnings-TTM | ₹19.2 Cr | TTM-Standalone Results |
| Price/Earnings | 9.37x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of CORAL LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹180.1 Cr] as on Nov 08,2026
(/) Earnings [ ₹19.2 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 9.37x ]
Thus, for CORAL LABORATORIES , the investors are currently willing to pay 9.37 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CORAL LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CORAL LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of CORAL LABORATORIES
PE Ratio Performance Analysis for CORAL LABORATORIES
- CORAL LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 9.92x.
- CORAL LABORATORIES 's operated at median p/e ratio of 10.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CORAL LABORATORIES 's p/e ratio peaked in Mar2023 at 12.69x.
- CORAL LABORATORIES 's p/e ratio hit its five-year low in Mar2026 of 8.08x.
How does CORAL LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| CORAL LABORATORIES | 19.21 | 9.37 | 180.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 41.63 | 459,497.0 |
| DIVIS LABORATORIES LTD | 3,363.00 | 87.47 | 294,146.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 86.46 | 181,474.0 |
| CIPLA LTD | 2,868.29 | 39.74 | 113,989.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.44 | 114,349.0 |
| MANKIND PHARMA LTD | 2,249.69 | 47.32 | 106,446.0 |
| LUPIN LTD | 5,221.47 | 17.47 | 91,230.0 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.78 | 119,700.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 26.02 | 103,913.0 |
| LAURUS LABS LTD | 1,333.75 | 96.01 | 128,054.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CORAL LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 9.37x |
| Max industry PE | 96.01x |
| Median industry PE | 41.44x |
| Average industry PE | 47.43x |
You may also like the below Video Courses